Reply [8]

American Journal of Ophthalmology

Volumn 141, Issue 1, 2006, Pages 228-229

  Jonas, Jost B ^a   Spandau, Ulrich H ^a   Harder, Bjoern ^a   Vossmerbaeumer, Urs ^a   Kamppeter, Bernd A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; TRIAMCINOLONE ACETONIDE;

DISEASE COURSE; EXUDATIVE RETINITIS; EYE EDEMA; FOLLOW UP; HUMAN; LETTER; MONOTHERAPY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; RETINA NEOVASCULARIZATION; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 29544442775     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2005.07.064     Document Type: Letter

References (5)

1. J.B. Jonas, U.H. Spandau, B. Harder, U. Vossmerbaeumer, B.A. Kamppeter Inter-eye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide Am J Ophthalmol 139 2005 1073 1079
2. J.B. Jonas, I. Kreissig, R.F. Degenring Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative and angiogenic diseases Prog Retin Eye Res 5 2005 587 611
3. R.F. Spaide, J. Sorenson, L. Maranan Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularisation Ophthalmology 110 2003 1517 1525
4. M.C. Gillies, J.M. Simpson, W. Luo A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration one-year results Arch Ophthalmol 121 2003 667 673
5. R.P. Danis, T.A. Ciulla, L.M. Pratt, W. Anliker Intravitreal triamcinolone acetonide in exudative age-related macular degeneration Retina 20 2000 244 250